BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37260126)

  • 1. Global uses of traditional herbs for hepatic diseases and other pharmacological actions: A comprehensive review.
    Choudhary A; Noman M; Bano U; Akhtar J; Shaikh Y; Yar MS
    Polim Med; 2023; 53(1):81-89. PubMed ID: 37260126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytosterols and Triterpenoids for Prevention and Treatment of Metabolic-related Liver Diseases and Hepatocellular Carcinoma.
    Sánchez-Crisóstomo I; Fernández-Martínez E; Cariño-Cortés R; Betanzos-Cabrera G; Bobadilla-Lugo RA
    Curr Pharm Biotechnol; 2019; 20(3):197-214. PubMed ID: 30806308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin and liver cancer: a review.
    Darvesh AS; Aggarwal BB; Bishayee A
    Curr Pharm Biotechnol; 2012 Jan; 13(1):218-28. PubMed ID: 21466422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Has selenium a chemopreventive effect on hepatocellular carcinoma?
    Costantini S; Lepore MG; Castello G; Colonna G
    Mini Rev Med Chem; 2011 Jun; 11(7):599-610. PubMed ID: 21699491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma.
    Bishayee A; Politis T; Darvesh AS
    Cancer Treat Rev; 2010 Feb; 36(1):43-53. PubMed ID: 19910122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese medicines for prevention and treatment of human hepatocellular carcinoma: current progress on pharmacological actions and mechanisms.
    Wang X; Wang N; Cheung F; Lao L; Li C; Feng Y
    J Integr Med; 2015 May; 13(3):142-64. PubMed ID: 26006028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma.
    Chen SR; Qiu HC; Hu Y; Wang Y; Wang YT
    Phytother Res; 2016 Jun; 30(6):863-77. PubMed ID: 26879574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Overview of Natural Plant Products in the Treatment of Hepatocellular Carcinoma.
    Rawat D; Shrivastava S; Naik RA; Chhonker SK; Mehrotra A; Koiri RK
    Anticancer Agents Med Chem; 2018; 18(13):1838-1859. PubMed ID: 29866017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive and therapeutic role of traditional Chinese herbal medicine in hepatocellular carcinoma.
    Ting CT; Li WC; Chen CY; Tsai TH
    J Chin Med Assoc; 2015 Mar; 78(3):139-44. PubMed ID: 25447209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
    Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
    Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary phytochemicals in the chemoprevention and treatment of hepatocellular carcinoma: in vivo evidence, molecular targets, and clinical relevance.
    Bishayee A; Thoppil RJ; Waghray A; Kruse JA; Novotny NA; Darvesh AS
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1191-232. PubMed ID: 22873222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenium in the prevention and treatment of hepatocellular carcinoma.
    Darvesh AS; Bishayee A
    Anticancer Agents Med Chem; 2010 May; 10(4):338-45. PubMed ID: 20380634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer, antioxidant, and hepatoprotective activity of
    Ansari S; Hasan K; Bhat S
    J Cancer Res Ther; 2021; 17(2):499-503. PubMed ID: 34121698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.
    Lodato F; Mazzella G; Festi D; Azzaroli F; Colecchia A; Roda E
    World J Gastroenterol; 2006 Dec; 12(45):7239-49. PubMed ID: 17143937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatocellular carcinoma].
    Semela D; Heim M
    Ther Umsch; 2011 Apr; 68(4):213-7. PubMed ID: 21452143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin-3-gallate in the prevention and treatment of hepatocellular carcinoma: experimental findings and translational perspectives.
    Bimonte S; Albino V; Piccirillo M; Nasto A; Molino C; Palaia R; Cascella M
    Drug Des Devel Ther; 2019; 13():611-621. PubMed ID: 30858692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma.
    Yuan L; Bing Z; Han J; An X; Liu X; Li R; Wang C; Sun X; Yang L; Yang K
    Biomed Pharmacother; 2020 Apr; 124():109838. PubMed ID: 31981943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
    Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
    J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function.
    Gnocchi D; Kapoor S; Nitti P; Cavalluzzi MM; Lentini G; Denora N; Sabbà C; Mazzocca A
    J Mol Med (Berl); 2020 Feb; 98(2):179-191. PubMed ID: 31863151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review.
    Aghemo A; Alekseeva OP; Angelico F; Bakulin IG; Bakulina NV; Bordin D; Bueverov AO; Drapkina OM; Gillessen A; Kagarmanova EM; Korochanskaya NV; Kucheryavii UA; Lazebnik LB; Livzan MA; Maev IV; Martynov AI; Osipenko MF; Sas EI; Starodubova A; Uspensky YP; Vinnitskaya EV; Yakovenko EP; Yakovlev AA
    Ann Med; 2022 Dec; 54(1):1548-1560. PubMed ID: 35635048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.